Condition: Vaso-Occlusive Pain Episode in Sickle Cell Disease · Sponsor: Nantes University Hospital
The purpose of the study is to determine whether adding lidocaine to standard of care in pain management during severe vaso-occlusive crisis has an effect on the cumulative opioid consumption expressed as morphine milligram equivalent.
This description comes directly from the study's public registry record.
Maïté AGBAKOU · 02.44.76.80.54 · maite.agbakou@chu-nantes.fr
Always discuss trial participation with your own doctor first.
| CHU Bordeaux | Bordeaux, France | Not Yet Recruiting |
| CHU Lille | Lille, France | Not Yet Recruiting |
| CHU La Timone | Marseille, France | Not Yet Recruiting |
| CHU de Nantes | Nantes, France | Recruiting |
| CHU Orléans | Orléans, France | Not Yet Recruiting |
| Hôpital Tenon APHP | Paris, France | Not Yet Recruiting |
| CHU Poitiers | Poitiers, France | Not Yet Recruiting |
| CHU Rouen | Rouen, France | Not Yet Recruiting |
| Oncopole Toulouse | Toulouse, France | Not Yet Recruiting |
| CHRU Tours - Hôpital Bretonneau | Tours, France | Not Yet Recruiting |
| CHU Guadeloupe | Les Abymes, Guadeloupe | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07274254